AS Latvijas Juras medicinas centrs (UOM.MU)
EUR 6.0
(0.0%)
EUR 6.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 431.38 Thousand EUR | -67.83% |
| 2022 | 992.97 Thousand EUR | -7.16% |
| 2021 | 1.17 Million EUR | 162.91% |
| 2020 | 519.03 Thousand EUR | 56.53% |
| 2019 | 244.89 Thousand EUR | 419.55% |
| 2018 | -16.87 Thousand EUR | -88.4% |
| 2017 | 765.13 Thousand EUR | -86.89% |
| 2016 | 618.27 Thousand EUR | 223.4% |
| 2015 | 267.25 Thousand EUR | 491.77% |
| 2014 | 1.48 Million EUR | -168.9% |
| 2013 | 309.44 Thousand EUR | -41.48% |
| 2012 | 605.24 Thousand EUR | 29.99% |
| 2011 | 471.2 Thousand EUR | 31.9% |
| 2010 | 358.16 Thousand EUR | -41.58% |
| 2009 | 605.49 Thousand EUR | -9.73% |
| 2008 | 670.72 Thousand EUR | -34.37% |
| 2007 | 1 Million EUR | 94.18% |
| 2006 | 526.32 Thousand EUR | -15.54% |
| 2005 | 623.15 Thousand EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 63.95 Thousand EUR | 573.29% |
| 2024 Q2 | -14.18 Thousand EUR | -86.37% |
| 2023 Q4 | -14.71 Thousand EUR | -103.61% |
| 2023 Q1 | -160.99 Thousand EUR | -144.32% |
| 2023 FY | - EUR | -67.83% |
| 2023 Q3 | 407.48 Thousand EUR | 548.13% |
| 2023 Q2 | -90.93 Thousand EUR | 43.52% |
| 2022 Q1 | 346.44 Thousand EUR | 29.41% |
| 2022 Q3 | 137.85 Thousand EUR | 221.07% |
| 2022 Q2 | -113.86 Thousand EUR | -132.87% |
| 2022 Q4 | 363.21 Thousand EUR | 163.47% |
| 2022 FY | - EUR | -7.16% |
| 2021 Q3 | 328.09 Thousand EUR | 232.97% |
| 2021 Q2 | 98.53 Thousand EUR | -43.32% |
| 2021 Q4 | 267.71 Thousand EUR | -18.41% |
| 2021 FY | - EUR | 162.91% |
| 2021 Q1 | 173.84 Thousand EUR | 420.92% |
| 2020 FY | - EUR | 56.53% |
| 2020 Q1 | 46.98 Thousand EUR | -3.68% |
| 2020 Q2 | 54.66 Thousand EUR | 16.34% |
| 2020 Q3 | 225.13 Thousand EUR | 311.86% |
| 2020 Q4 | -54.17 Thousand EUR | -124.06% |
| 2019 Q4 | 48.78 Thousand EUR | -72.13% |
| 2019 Q1 | -18.47 Thousand EUR | -145.77% |
| 2019 Q3 | 175.04 Thousand EUR | 211.25% |
| 2019 FY | - EUR | 419.55% |
| 2019 Q2 | -157.34 Thousand EUR | -751.82% |
| 2018 Q1 | 91.38 Thousand EUR | -52.96% |
| 2018 FY | - EUR | -88.4% |
| 2018 Q4 | 40.36 Thousand EUR | -34.35% |
| 2018 Q3 | 61.47 Thousand EUR | 142.08% |
| 2018 Q2 | -146.08 Thousand EUR | -259.86% |
| 2017 Q2 | -190.09 Thousand EUR | -197.45% |
| 2017 Q1 | 195.07 Thousand EUR | -93.14% |
| 2017 FY | - EUR | -86.89% |
| 2017 Q3 | 207.11 Thousand EUR | 208.96% |
| 2017 Q4 | 194.25 Thousand EUR | -6.21% |
| 2016 Q1 | -8329.00 EUR | -104.75% |
| 2016 Q4 | 2.84 Million EUR | 1813.51% |
| 2016 FY | - EUR | 223.4% |
| 2016 Q3 | 148.52 Thousand EUR | 228.65% |
| 2016 Q2 | -115.44 Thousand EUR | -1286.11% |
| 2015 Q4 | 175.49 Thousand EUR | 6509.87% |
| 2015 Q3 | 2655.00 EUR | -96.17% |
| 2015 Q1 | 19.83 Thousand EUR | -77.55% |
| 2015 Q2 | 69.27 Thousand EUR | 249.16% |
| 2015 FY | - EUR | 491.77% |
| 2014 Q4 | 88.37 Thousand EUR | -71.1% |
| 2014 Q1 | 222.7 Thousand EUR | -13.59% |
| 2014 Q3 | 305.77 Thousand EUR | 182.95% |
| 2014 FY | - EUR | -168.9% |
| 2014 Q2 | 108.06 Thousand EUR | -51.47% |
| 2013 Q4 | 257.73 Thousand EUR | 30.06% |
| 2013 FY | - EUR | -41.48% |
| 2013 Q3 | 198.17 Thousand EUR | 393.43% |
| 2013 Q1 | -33.42 Thousand EUR | -107.64% |
| 2013 Q2 | -67.53 Thousand EUR | -102.03% |
| 2012 Q4 | 437.8 Thousand EUR | 885.28% |
| 2012 FY | - EUR | 29.99% |
| 2012 Q1 | 136.7 Thousand EUR | -46.83% |
| 2012 Q2 | -12.43 Thousand EUR | -109.1% |
| 2012 Q3 | 44.43 Thousand EUR | 457.31% |
| 2011 Q2 | -45.65 Thousand EUR | -131.44% |
| 2011 FY | - EUR | 31.9% |
| 2011 Q1 | 145.22 Thousand EUR | 54.4% |
| 2011 Q4 | 257.13 Thousand EUR | 134.03% |
| 2011 Q3 | 109.87 Thousand EUR | 340.64% |
| 2010 Q4 | 94.05 Thousand EUR | -77.48% |
| 2010 Q1 | -1821.03 EUR | -101.57% |
| 2010 FY | - EUR | -41.58% |
| 2010 Q2 | -156.11 Thousand EUR | -8473.01% |
| 2010 Q3 | 417.61 Thousand EUR | 367.5% |
| 2009 Q2 | 172.55 Thousand EUR | -13.55% |
| 2009 Q3 | 117.66 Thousand EUR | -31.81% |
| 2009 FY | - EUR | -9.73% |
| 2009 Q4 | 115.65 Thousand EUR | -1.7% |
| 2009 Q1 | 199.61 Thousand EUR | 0.0% |
| 2008 FY | - EUR | -34.37% |
| 2007 FY | - EUR | 94.18% |
| 2006 FY | - EUR | -15.54% |
| 2005 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|